Uveal Melanoma - Comparative Study
Rekrutierend
NCT-Nummer:
NCT06284512
Studienbeginn:
Oktober 2023
Letztes Update:
29.02.2024
Wirkstoff:
-
Indikation (Clinical Trials):
Melanoma, Uveal Neoplasms
Geschlecht:
Alle
Altersgruppe:
Erwachsene (18+)
Phase:
-
Sponsor:
Medical University of Vienna
Collaborator:
-
Studienleiter
Reinhard Told, MD, PhD, Priv.-Doz. Principal InvestigatorDeparment of Ophthalmology and Optometry
Kontakt
Reinhard Told, MD, PhD, Priv.-Doz. Kontakt: Phone: +43 40400 79690 E-Mail: reinhard.told@meduniwien.ac.at» Kontaktdaten anzeigen
Judith Kreminger, MD Kontakt: Phone: +43 40400 48470 E-Mail: judith.kreminger@meduniwien.ac.at» Kontaktdaten anzeigen
Brief Summary: The progress of uveal melanoma is typically monitored with sonography by experienced onco-ophthalmologists. However, there is evidence that twodimensional measurements in color fundus photography match precisely with sonography measurements. This study aims to compare sonography and color fundus photography measurements in order to evaluate the feasibility of monitoring of uveal melanoma with color fundus photography.
Inclusion Criteria: - Diagnosis of uveal melanomaExclusion Criteria: - Inadequate or missing information on the clinical course in patient charts - Imaging not feasible due to any reason.
Primary outcome: 1. Largest Basal Diameter (Time Frame - 1 day):Largest Basal Diameter will be measured on echography and color fundus photography
Sonography, color fundus photography:Patients will undergo routine diagnostic imaging (Sonography, color fundus photography)
Quelle: ClinicalTrials.gov
Sie können folgenden Inhalt einem Kollegen empfehlen:
"Uveal Melanoma - Comparative Study"
Bitte tragen Sie auch die Absenderdaten vollständig ein, damit Sie der Empfänger erkennen kann.
Die mit (* ) gekennzeichneten Angaben müssen eingetragen werden!